Clinico-demographic parameters | ESP, (n = 37) | TEA, (n = 37) | |
---|---|---|---|
Age in years | (Mean ± SD) | 61.27 ± 12.60 | 59.22 ± 10.69 |
Gender, n (%) | Male | 26 (70.3) | 27 (73.0) |
Female | 11 (29.7) | 10 (27.0) | |
Anthropometry, mean ± SD | Height in cms | 166.24 ± 8.76 | 164.43 ± 10.01 |
Weight in kgs | 69.76 ± 13.02 | 68.51 ± 13.27 | |
BMI in kg/m2 | 25.14 ± 3.74 | 25.18 ± 3.54 | |
ASA, n (%) | II | 1 (2.70%) | 4 (10.81%) |
III | 34 (91.89%) | 30 (81.08%) | |
IV | 2 (5.40%) | 3 (8.10%) | |
MPG, n (%) | I | 2 (5.41%) | 0 |
II | 32 (86.48%) | 34 (91.89%) | |
III | 3 (8.11%) | 3 (8.11) | |
Surgeries performed, n (%) | ASD closure | 0 | 3 (8.10%) |
MVR | 3 (8.10%) | 1 (2.70%) | |
AVR | 2 (5.40%) | 0 | |
CABG | 30 (81.08%) | 32 (86.48%) | |
LA myx removal | 1 (2.70%) | 1 (2.70%) | |
LA myx removal + CABG | 1 (2.70%) | 0 | |
LVEF % | (Mean ± SD) | 54.41 ± 5.77 | 51.05 ± 3.86 |